Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 1, 1999, Pages 147-153

  Shih, Tsung Ming ^a   McDonough Jr , John H ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Anticholinergic compounds; Anticonvulsants; Atropine sulfate; Cholinesterase inhibitors; Convulsions; EEG activity; GF; Nerve agents; Organophosphorus compounds; Sarin; Seizures; Soman; Tabun; VX

Indexed keywords

ATROPINE; CYCLOSARIN; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; ORGANOPHOSPHATE; PRALIDOXIME CHLORIDE; PYRIDOSTIGMINE; SARIN; SOMAN; TABUN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROENCEPHALOGRAM; GUINEA PIG; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; ATROPINE; CHEMICAL WARFARE AGENTS; ELECTROENCEPHALOGRAPHY; GUINEA PIGS; MALE; MUSCARINIC ANTAGONISTS; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 0032872680     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00114-8     Document Type: Article

References (37)

1. Berry W., Davis D.R. The use of carbamates and atropine in protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19:1970;927-934.
2. Bliss, C.I.: The statistics of bioassay with special reference to the vitamins. In: Vitamin Methods, vol. II. New York: Academic Press; 1952.
3. Boskovic B. The treatment of soman poisoning and its perspectives. Fundam. Appl. Toxicol. 1:1981;203-213.
4. Capacio B.R., Shih T.-M. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia. 32:1991;604-615.
5. Clement J.G., Broxup B. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. Neurotoxicology. 14:1993;485-504.
6. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14:1994;317-331.
7. Dirnhuber P., French M.C., Green D.M., Leadbeater L., Stratton J.A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:1979;295-299.
8. Dunn M.A., Sidell F.R. Progress in medical defense against nerve agents. JAMA. 262:1989;649-652.
9. Fleisher J.H., Harris L.W. Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolylmethylphosphonofluoridate. Biochem. Pharmacol. 14:1965;641-650.
10. Glenn J.F., Hinman D.J., McMaster S.B. Electroencephalographic correlates of nerve agent poisoning. Dun N.J., Perlman R.L. Neurobiology of acetylcholine. 1987;503-534 Plenum Press, New York.
11. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., Nold J.B. Decreased brain pathology of organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J. Neurol. Sci. 98:1990;99-106.
12. Johnson D.D., Wilcox W.C. Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning. Eur. J. Pharmacol. 34:1975;127-132.
13. Kadar T., Shapira S., Cohen G., Sahar R., Alkalay D., Raveh L. Sarin-induced neuropathology in rats. Hum. Exp. Toxicol. 14:1995;252-259.
14. Kluwe, W. M.; Chinn, J. W.; Feder, J. W.; Olson, C.; Joiner, R.: Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model. In: Proceedings of the Sixth Medical Chemical Defense Bioscience Review, AD No. B121516. Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense; 1987:227-234.
15. Koplovitz I., Skvorak J.P. Electrocorticographic changes during generalized convulsive status epilepticus in soman intoxicated rats. Epilepsy Res. 30:1998;159-164.
16. Lemercier G., Carpentier P., Sentenac-Roumanou H., Moralis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. (Berl.). 61:1983;123-129.
17. Lennox W.J., Harris L.W., Talbot B.G., Anderson D.R. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci. 37:1985;793-798.
18. Lipp J.A. Cerebral electrical activity following soman administration. Arch Int. Pharmacodyn. Ther. 175:1968;161-169.
19. Lipp J.A. Effect of diazepam upon soman-induced seizure activity and convulsions. EEG Clin. Neurophysliol. 32:1972;557-560.
20. Lipp J.A. Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch. Int. Pharmacodyn. Ther. 202:1973;244-251.
21. McDonough J.H., Dochterman L.W., Smith C.D., Shih T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology. 15:1995;123-132.
22. McDonough J.H., Jaax N.K., Crowley R.A., Mays, Modrow M.Z. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13:1989;256-276.
23. McDonough J.H., Shih T.-M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17:1993;203-215.
24. McDonough J.H., Shih T.-M. Neuropharmacological mechanisms of nerve agent-induced seizures and neuropathology. Neurosci. Biobehav. Rev. 21:1997;559-579.
25. McLeod C.G., Singer A.W., Harrington D.G. Acute neuropathology in soman poisoned rats. Neurotoxicology. 5:1984;53-58.
26. Moore D.H., Clifford C.B., Crawford I.T., Cole G.M., Baggett J.M. Review of nerve agent inhibitors and reactivators of acetylcholinesterase. Quinn D.M., Balasubramanian A.S., Doctor B.P., Taylor P. Enzymes of the cholinesterase family. 1995;297-304 Plenum Press, New York.
27. Petras J.M. Soman neurotoxicity. Fundam. Appl. Toxicol. 1:1981;242.
28. Petras J.M. Neurology and neuropathology of soman-induced brain injury. An overview J. Exp. Anal. Behav. 61:1994;319-329.
29. Rump S., Grudzinska E., Edelwein Z. Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit's brain induced by fluostigmine. Neuropharmacology. 12:1973;813-817.
30. Shih T.-M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7:1990;105-116.
31. Shih T.-M., Koplovitz I., McDonough J.H. Evaluation of anticonvulsant drugs for soman-induced seizure activity. J. Am. Coll. Toxicol. 15(Suppl. 2):1996;S43-S60.
32. Shih T.-M., Koviak T.A., Capacio B.R. Anticonvulsants for poisoning by the organophosphorus compound soman. Pharmacological mechanisms Neurosci. Biobehav. Rev. 15:1991;349-362.
33. Shih, T.-M.; McDonough, J. H.: Pharmacological antagonism of nerve agent-induced seizures. In: Proceedings of the 1996 medical defense bioscience review, AD No. A321840, Vol. I. Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense; 1996:435-446.
34. Shih T.-M., Whalley C.E., Valdes J.J. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol. Lett. 55:1991;131-147.
35. Taylor P. Anticholinesterase agents. Gilman A.G., Goodman L.S., Rall T.W., Murad F. The pharmacological basis of therapeutics. 6th ed:1985;110-129 Macmillan, New York.
36. Thornton, K. R.; Brigden, E. G.: Morphological changes in the brains of guinea pigs following VX poisoning. Suffield Tech. Pap. No. 230. 1962.
37. Thornton, K. R.; Fukuyama, G. S.: Morphological changes in the brains of M. Mulatta treated for VX poisoning with atropine, metaraminol and P2S. Suffield Tech. Pap. No. 228. 1961.